Manhattan Scientifics, Inc. (MHTX)
OTCMKTS
· Delayed Price · Currency is USD
0.0006
-0.0001 (-14.29%)
Dec 20, 2024, 4:00 PM EST
Manhattan Scientifics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 0.04 | 0.07 | 0.18 | 0.23 | 0.35 | 0.26 | Upgrade
|
| Cash & Short-Term Investments | 0.04 | 0.07 | 0.18 | 0.23 | 0.35 | 0.26 | Upgrade
|
| Cash Growth | -26.92% | -61.71% | -24.57% | -34.28% | 35.25% | 200.00% | Upgrade
|
| Other Receivables | - | - | - | 0.3 | 0.3 | 0.3 | Upgrade
|
| Receivables | - | - | - | 0.3 | 0.3 | 0.3 | Upgrade
|
| Prepaid Expenses | 0.01 | 0 | 0.01 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Total Current Assets | 0.05 | 0.07 | 0.19 | 0.55 | 0.67 | 0.57 | Upgrade
|
| Property, Plant & Equipment | - | - | 0 | 0 | 0.01 | 0 | Upgrade
|
| Long-Term Investments | 0.03 | 0.25 | 0.84 | 2.9 | 5.88 | 1.05 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0 | 0 | 0.3 | 0.6 | Upgrade
|
| Total Assets | 0.07 | 0.32 | 1.03 | 3.45 | 6.85 | 2.23 | Upgrade
|
| Accounts Payable | 0.16 | 0.13 | 0.12 | 0.1 | 0.16 | 1.51 | Upgrade
|
| Accrued Expenses | 2.18 | 1.92 | 1.44 | 1.13 | 0.85 | 0.58 | Upgrade
|
| Current Portion of Long-Term Debt | 0.06 | 0.06 | 0.11 | 0.13 | - | - | Upgrade
|
| Current Unearned Revenue | 0.02 | 0.01 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 2.42 | 2.12 | 1.67 | 1.36 | 1.01 | 2.09 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.1 | 0.08 | Upgrade
|
| Total Liabilities | 2.42 | 2.12 | 1.67 | 1.36 | 1.12 | 2.17 | Upgrade
|
| Common Stock | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | 0.56 | Upgrade
|
| Additional Paid-In Capital | 69 | 69 | 69 | 69 | 69 | 67.63 | Upgrade
|
| Retained Earnings | -72.96 | -72.42 | -71.25 | -68.52 | -64.88 | -69.2 | Upgrade
|
| Total Common Equity | -3.4 | -2.86 | -1.7 | 1.04 | 4.67 | -1.01 | Upgrade
|
| Shareholders' Equity | -2.34 | -1.8 | -0.64 | 2.09 | 5.73 | 0.05 | Upgrade
|
| Total Liabilities & Equity | 0.07 | 0.32 | 1.03 | 3.45 | 6.85 | 2.23 | Upgrade
|
| Total Debt | 0.06 | 0.06 | 0.11 | 0.13 | 0.1 | 0.08 | Upgrade
|
| Net Cash (Debt) | -0.02 | 0.01 | 0.07 | 0.1 | 0.25 | 0.18 | Upgrade
|
| Net Cash Growth | - | -89.23% | -36.27% | -59.04% | 36.07% | 110.34% | Upgrade
|
| Net Cash Per Share | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Upgrade
|
| Filing Date Shares Outstanding | 559.28 | 559.28 | 559.28 | 559.28 | 559.28 | 557.78 | Upgrade
|
| Total Common Shares Outstanding | 559.28 | 559.28 | 559.28 | 559.28 | 559.28 | 557.78 | Upgrade
|
| Working Capital | -2.37 | -2.05 | -1.48 | -0.81 | -0.35 | -1.52 | Upgrade
|
| Book Value Per Share | -0.01 | -0.01 | -0.00 | 0.00 | 0.01 | -0.00 | Upgrade
|
| Tangible Book Value | -3.4 | -2.86 | -1.7 | 1.04 | 4.67 | -1.01 | Upgrade
|
| Tangible Book Value Per Share | -0.01 | -0.01 | -0.00 | 0.00 | 0.01 | -0.00 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.